Market's Pharma Shield

Sensex down 800 points, but Nifty Pharma up. While market routs on US tariff fears, pharma is outlier. Defensive buying, US generic hope.

Parched Dreams

Monsoon promised, then vanished for 67 days. In Sakri's tribal belt, maize burns and groundnuts rot half-grown. Maharashtra's drought is not just crop...

Fortress India

Foreign Exchange Reserves Skyrocket to Historic Highs: According to the latest data released by the Reserve Bank of India (RBI), India's foreign exch...

Market Meltdown? Far From It

September IPO Blitz Walks Away with ₹38,785 Crore. This figure marks one of the highest amounts ever raised via IPOs in a single month in the history...

The Suck

RBI's Rs 71,971 Crore Vacuum: RBI on Tuesday absorbed Rs 71,971 crore from banking system through overnight variable rate reverse repo auction amid hu...

New Frontier in Digital Payments

UPI Merchant Charges and the Economic Framework: A fresh economic debate has emerged in India regarding the regulations and financial structure of t...

EPFO Wage Ceiling Set to Rise

The Central Government has taken a significant welfare-oriented decision aimed at expanding the mandatory social security coverage under the Employees...

Global Turbulence Sends Gold, Silver Soaring

Amidst ongoing turmoil in international markets and looming signs of a global economic slowdown, gold and silver prices in the bullion market have hit...

Historic Bull Run: Sensex and Nifty Rocket to All-Time High

The Indian stock market has once again created history, bringing smiles to the faces of investors. Upon opening, the Bombay Stock Exchange (BSE) Sense...